Immune Profiling During Ocrelizumab Treatment in Multiple Sclerosis

Clinical trial NCT03138525 · COMPLETED

Trial details

NCT number: NCT03138525
Sponsor: Brigham and Women's Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis Healthy

Start date: 2017-06-20
Primary completion: 2019-12-20
Enrollment: 161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.